SG Americas Securities’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,278	Closed	-$257K	–	3213
2020 Q2	$257K	Buy	+17,278	New	+$257K	﹤0.01%	2268
2019 Q3	–	Sell	-14,706	Closed	-$194K	–	2764
2019 Q2	$194K	Buy	+14,706	New	+$194K	﹤0.01%	2092